Search

The Dutch company is bolstering Málaga’s advanced technology ecosystem with a total investment of €32 million.

Innovation in healthcare does not arise solely from good ideas, but from an institutional architecture capable of attracting talent, coordinating capabilities and accelerating translation.

The agreement combines the preclinical models developed by the Institute of Biomedical Research of Barcelona (IIBB-CSIC) with the computational design platform of the company Chemotargets, based at

Meet PLOID AI, our new member. We spoke with Adolfo Gastalver Rubio and Federico Jurado Ruiz, CO-Founders.

Updated data from iadademstat’s clinical trials in acute myeloid leukemia to be presented at EHA-2026 in June.

MedTech Barcelona took part in the Spain–United States Business Meeting in Boston, held on April 13 and 14.

The Bilbao Exhibition Centre will host the next edition of BIOSPAIN from September 29 to October 1.

At AseBio, we reaffirm our commitment to continuing to work with European and national institutions to ensure that the implementation of the Regulation fully harnesses the potential of NGTs in support

The strategic framework agreement deepens the long-standing partnership, leveraging Artificial Intelligence and High-Performance Computing to identify new opportunities of collaboration in the

The event, organized by AseBio and the Salamanca City Council, was held this Tuesday at the Congress and Exhibition Center of the Tormes capital. It brought together 120 attendees from 75

We interviewed Germán Alejandro Sánchez Martín, Founder & CEO of Opportunity Health, the company that won the BIOSPAIN 2025 Pitch Presentation.

The announcement was made during the Spain–United States Business Meeting held in Boston, organized by ICEX España Exportación e Inversiones, with the participation of 40 Spanish companies and nearly